Does sulphoxidation state predict gold toxicity in rheumatoid arthritis?
Gold (sodium aurothiomalate) is commonly used as a disease modifying agent in rheumatoid arthritis. Its use is, however, limited by occurrence of toxic reactions, which may develop in up to 45% of patients.' The mechanism of toxicity is not clear, although a genetic basis for haematological and renal toxicity has been shown.2 Penicillamine and captopril are also effective disease modifying drugs and share a similar toxicity profile to sodium aurothiomalate.3 All three drugs have in common a sulphydryl group: their toxicity and efficacy may be due to parent sulphydryl groups or a toxic metabolite of oxidation of sulphur.
The oxidation of some sulphydryl groups is thought to be mediated by a hepatic flavoprotein oxidase.4 The ability of this or an associated enzyme system to handle sulphydryl groups seems to correlate with ability to oxidise sulphur, as measured by the ratio of free sulphides to sulphoxides after a fixed oral dose of carbocisteine (another drug containing sulphur); this ratio is the sulphoxidation index. Patients with rheumatoid arthritis with a poor sulphoxidation state are more susceptible to penicillamine toxicity5; we assessed whether they are also more susceptible to sodium aurothiomalate toxicity.
Patients, methods, and results
We studied 30 randomly selected patients with classical or definite rheumatoid arthritis who had received sodium aurothiomalate; 14 had developed a toxic reaction, while the remaining 16 had received sodium aurothiomalate for more than one year without adverse effect. After an overnight fast each patient received 750 mg carbocisteine (Mucodyne, Berk); after one hour patients were given their daily medication and allowed to eat freely. All urine passed for eight hours was collected, the volume recorded, and a 10 ml aliquot stored at -4°C.
The urine was analysed for the sulphide and sulphoxide metabolites of carbocisteine by paper chromatography; compounds were visualised by the chloroplatinate reaction and measured by planimetric densitometry.4 The sulphoxidation index was derived from the ratio of excreted sulphides to sulphoxides. A value >6 was taken as indicating an impaired ability to metabolise carbocisteine (poor sulphoxidation state) and s<6 a good ability to handle carbocisteine.4
Of the 14 patients who had suffered adverse reactions, 13 had a low sulphoxidation index ( Fisher's exact test, p<002.
developed an adverse reaction-namely, mouth ulceration (p<0-02, Fisher's exact test (two tailed)). The relative risk of a patient with a poor sulphoxidation state developing a toxic reaction was 5 *9. In those with a poor sulphoxidation state there was no apparent relation between the degree of impairment of sulphoxidation and type of toxicity.
Comment
This study is the first to show that patients with an impaired ability to metabolise carbocisteine are predisposed to sodium aurothiomalate toxicity. The relative risk is similar to that found for penicillamine. In a previous study haematological and renal toxic reactions to sodium aurothiomalate were strongly associated with major histocompatibility type HLA-DR3.2 A preliminary study, however, suggested that poor sulphoxidation state and HLA-DR3 were independent, so both variables may need to be considered.5
An interesting additional observation in our study was the unexpectedly high prevalence of patients with a poor sulphoxidation state (67%) compared with the proportion in the general population (22%)4; this observation needs to be confirmed in an unselected patient population to exclude selection bias. If our findings are confirmed in a cohort of patients treated prospectively with sodium aurothiomalate then suiphoxidation state should prove to be useful in improving the risk:benefit ratio of sodium aurothiomalate in rheumatoid arthritis; it may also be an interesting pharmacogenetic probe into the pathogenesis of rheumatoid arthritis.
Acute pancreatitis: a new finding in cryptosporidium enteritis
Cryptosporidium is a coccidian parasite that, since its first description in man in 1976, has become increasingly recognised as a cause of acute enterocolitis.' It has also, however, been recovered from the lung2 and gall bladder3 as well as from the pancreatic duct.4 We report on a patient with cryptosporidial enteritis and acute pancreatitis.
Case report A previously healthy 14 year old farmer's daughter was admitted to hospital in May 1986 with acute abdominal pain. One week before admission she had developed diffuse colicky abdominal pain associated with anorexia, nausea, vomiting, watery diarrhoea, and a temperature of 39°C. These symptoms resolved after four days. A faecal specimen submitted by her general practitioner contained large numbers of cryptosporidium oocysts. On the day of admission her abdominal pain recurred and worsened. She did not have a history of recent abdominal trauma or familial pancreatitis.
On examination she was pale, dehydrated, and obviously in pain, but afebrile. Her abdomen was soft with tenderness and guarding centrally and over the epigastrium. Bowel sounds and the results of rectal examination were normal. Gastroenteritis was initially diagnosed. Investigations showed: haemoglobin 131 g/l, white cell count 29 lx 109/1, blood glucose 10-5 mmol/l, serum amylase 14400 (normal <300) U/1, calcium 2-3 mmol/l, and normal concentrations of urea and electrolytes. The results of serological tests for antibodies to influenza A and B, adenovirus, Chiamydia psittaci, Mycoplasma pneumoniae, Coxiella burnetii, measles, mumps, varicella zoster, cytomegalovirus, respiratory syncitial virus, and coxsackie B were all negative. Markers for hepatitis A and B were not detected. Serum cholesterol, high density lipoprotein, and low density lipoprotein concentrations were not increased. Autoantibodies were not detected. Cryptosporidium specific antibody titres obtained by a fluorescence antibody test were consistent with recent infection. A chest x ray film showed some bilateral basal consolidation with bilateral effusions while an abdominal x ray film was normal. Acute pancreatitis was diagnosed, and intravenous fluid replacement and nasogastric aspiration were started. Abdominal ultrasound showed enlargement ofthe pancreas and ascites. A repeat faecal examination showed a reduction in the number of cryptosporidium oocysts; none could be detected after one week.
She recovered slowly and became asymptomatic after two weeks. Though an ultrasound scan showed a pancreatic pseudocyst 5 5 cm in diameter she was allowed home. At six weeks it had almost resolved. Increased pancreatic echogenicity at this time suggested the possibility of chronic pancreatitis. Gall stones were not identified. Though the patient remained well her progress was monitored, and she had an endoscopic retrograde cholangiopancreatographic examination.
Comment
The method of transmission of cryptosporidium is still debatable. It was originally thought to be zoonotic, but recent work suggests that person to person transmission is common (D Casemore, personal communication).
Our patient worked with her parents' cattle and drank untreated milk: both are considered to be possible sources of infection.
Most reports of cryptosporidium enteritis have described an association with the acquired immune deficiency syndrome and a limitation to the gastrointestinal tract. Subsequently the disease has occurred in patients with a normal immune system and in other organs, suggesting possible haematogenous spread.
This patient presented with typical gastroenteritis except for the severity of the abdominal pain. Cryptosporidium causes more intense abdominal pain than Giardia lamblia, and cramps are more common.5 Although our patient may be an isolated example, we wonder whether some infected patients who complain of severe pain may be suffering from acute pancreatitis. We suggest therefore that cryptosporidium may be an additional aetiological factor in the cause of acute pancreatitis.
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With the increasing prevalence ofthe acquired immune deficiency syndrome (AIDS) and seropositivity to human immunodeficiency virus (HIV) health workers need to be cautious in handling body fluids. We report on a patient in whom HIV was isolated from synovial fluid aspirated from a knee joint.
Case report A 37 year old homosexual man presented with a four day history of profuse watery diarrhoea followed, after seven days, by migratory joint pains. On admission he was feverish (temperature 37-8°C) and had appreciably reduced neck movements, bilateral knee effusions, and tender wrists. On investigation his haemoglobin concentration was 116 g/l, white cell count 5 9x10 g/l, and C reactive protein concentration 66 mg/l (normal <5 mg/I). Routine blood, stool, and urine cultures yielded negative results, as did a test for hepatitis B surface antigen and a Monospot test. Antibodies to Chlamydia trachomatis were not found. IgG antibody to HIV was detected by enzyme linked immunosorbent assay and indirect membrane immunofluorescence in serum obtained one week before his admission to hospital. A subsequent sample was shown to contain IgG and 1gM antibodies by indirect membrane immunofluorescence. Antibody to Salmonella paratyphi was present at a titre of 11640. The erythrocyte sedimentation rate before admission was 64 mm in the first hour. x Ray pictures were normal. Synovial fluid aspirated from the right knee was mildly cloudy and straw coloured. It contained IgG but not IgM antibody to HIV.
Isolation of virus-The virus was isolated by two culture methods: a small volume of synovial aspirate (A) was cocultured with normal peripheral blood lymphocytes stimulated by phytohaemagglutinin, the ratio of synovial cells to lymphocytes being 1:3'; and a second culture (B) was established with Hut 78 cells. Viral growth was detected by observation of cytopathic effects, immunofluorescence, and reverse transcriptase assays.2 After 11 days infectious retrovirus was identified in culture A by a peak in particle associated reverse transcriptase activity in the supernatant fluid (figure). Synctial formation was noted in culture B after 20 days, and four days later viral antigens were detected by indirect membrane immunofluorescence.
The patient was treated with bed rest, anti-inflammatory drugs, and a continuing course of tetracycline. He had an intermittent fever at night, and 10 days later lymph nodes in both axillas and inguinal regions were palpable. His joint symptoms had improved before his discharge from hospital.
Although no retrovirus has been implicated in the pathogenesis ofarthritis in man, a member of the same subfamily as HIV, caprine arthritis encephalitis virus, causes arthritis in goats.3 Though patients with AIDS commonly complain of arthralgia, arthropathy has not been described; in this case there was no direct evidence that HIV was the cause of the arthritis. Possibly our patient was suffering from a reactive arthritis and lymphocytes invading the inflamed knee joint were infected with HIV. The clinical presentation of the joint manifestations was not, however, typical of a reactive arthritis: the pronounced neck stiffness and tenderness of the cervical spine on palpation and thereafter were unusual. The lack of stiffness on neck flexion and the relative lack of tenderness associated with lymphadenopathy further supported the diagnosis of arthritis affecting the cervical spine. Whether HIV can cause arthritis must, we believe, remain an open question. The isolation of HIV from synovial fluid is important for those dealing with patients suffering from reactive arthritides of whatever cause. It re-emphasises the need to apply safety precautions whenever exposure to body fluid is likely, and it raises the question whether it is appropriate to use intra-articular steroids in patients who are positive for antibody to HIV.
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